Everolimus pharmacokinetics and exposure-response relationship in Japanese patients with advanced breast cancer

Background: Everolimus is one of the key drugs for the treatment of advanced breast cancer. The optimal target concentration range for everolimus therapy in patients with breast cancer has not yet been established. This study aimed to characterize everolimus pharmacokinetics (PK) and determine the r...

Full description

Saved in:
Bibliographic Details
Main Authors: Masaki Hirabatake (Author), Tomoyuki Mizuno (Author), Hironori Kato (Author), Tohru Hashida (Author)
Format: Book
Published: Frontiers Media S.A., 2022-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available